NEXUSPHARMA, INC

Follow

Organization

LANGHORNE, PA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
C-Myc as a biomarker for tumor sensitivity to treatment with RNA po...
- Patent number 10,328,050
- Issue date Jun 25, 2019
- Institute for Cancer Research
- Igor Astsaturov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating MYC-amplified tumors with RNA-polymerase II inhi...
- Patent number 9,993,458
- Issue date Jun 12, 2018
- Institute for Cancer Research
- Igor Astsaturov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydro-isoquinolines
- Patent number 8,367,699
- Issue date Feb 5, 2013
- NexusPharma, Inc.
- Lutz Weber
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydro-isoquinolin-1-ones for the treatment of cancer
- Patent number 8,163,744
- Issue date Apr 24, 2012
- NexusPharma, Inc.
- Lutz Weber
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
C-MYC As A Biomarker For Tumor Sensitivity To Treatment With RNA Po...
- Publication number 20180263955
- Publication date Sep 20, 2018
- Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cance...
- Igor Astsaturov
- C07 - ORGANIC CHEMISTRY